Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Alcon stock | $69.68

Learn how to easily invest in Alcon stock.

Alcon Inc
NYSE: ALC - USD
MEDICAL INSTRUMENTS & SUPPLIES
$73.02
+$0.98 (+1.36%)

Alcon Inc is a medical instruments & supplies business based in the US. Alcon shares (ALC) are listed on the NYSE and all prices are listed in US Dollars. Alcon employs 23,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Alcon

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ALC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Alcon stock price (NYSE: ALC)

Use our graph to track the performance of ALC stocks over time.

Alcon shares at a glance

Information last updated 2021-07-22.
Latest market close$69.68
52-week range$54.35 - $76.31
50-day moving average $70.14
200-day moving average $70.90
Wall St. target price$77.58
PE ratio N/A
Dividend yield $0.113 (0.16%)
Earnings per share (TTM) $-0.74

Buy Alcon shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Alcon stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Alcon price performance over time

Historical closes compared with the close of $69.68 from 2021-05-28

1 week (2021-07-19) N/A
1 month (2021-06-30) -0.83%
3 months (2021-04-30) -7.62%
6 months (2021-01-26) N/A
1 year (2020-07-26) N/A
2 years (2019-07-26) N/A
3 years (2018-07-26) N/A
5 years (2016-07-26) N/A

Is Alcon under- or over-valued?

Valuing Alcon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alcon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Alcon's EBITDA

Alcon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.

The EBITDA is a measure of a Alcon's overall financial performance and is widely used to measure a its profitability.

Alcon financials

Revenue TTM $6.9 billion
Gross profit TTM $3.1 billion
Return on assets TTM -0.17%
Return on equity TTM -2.05%
Profit margin -5.63%
Book value $38.61
Market capitalisation $35.3 billion

TTM: trailing 12 months

Shorting Alcon shares

There are currently 6.4 million Alcon shares held short by investors – that's known as Alcon's "short interest". This figure is 11.9% up from 5.7 million last month.

There are a few different ways that this level of interest in shorting Alcon shares can be evaluated.

Alcon's "short interest ratio" (SIR)

Alcon's "short interest ratio" (SIR) is the quantity of Alcon shares currently shorted divided by the average quantity of Alcon shares traded daily (recently around 708683.42602892). Alcon's SIR currently stands at 8.99. In other words for every 100,000 Alcon shares traded daily on the market, roughly 8990 shares are currently held short.

However Alcon's short interest can also be evaluated against the total number of Alcon shares, or, against the total number of tradable Alcon shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alcon's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Alcon shares in existence, roughly 10 shares are currently held short) or 0.013% of the tradable shares (for every 100,000 tradable Alcon shares, roughly 13 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Alcon.

Find out more about how you can short Alcon stock.

Alcon share dividends

19%

Dividend payout ratio: 19.4% of net profits

Recently Alcon has paid out, on average, around 19.4% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Alcon shareholders could enjoy a 0.16% return on their shares, in the form of dividend payments. In Alcon's case, that would currently equate to about $0.113 per share.

While Alcon's payout ratio might seem low, this can signify that Alcon is investing more in its future growth.

Alcon's most recent dividend payout was on 5 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 3 May 2021 (the "ex-dividend date").

Alcon share price volatility

Over the last 12 months, Alcon's shares have ranged in value from as little as $54.352 up to $76.3081. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Alcon's is 0.4739. This would suggest that Alcon's shares are less volatile than average (for this exchange).

Alcon overview

Alcon, Inc. , an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S. A.

Frequently asked questions

What percentage of Alcon is owned by insiders or institutions?
Currently 0.057% of Alcon shares are held by insiders and 61.72% by institutions.
How many people work for Alcon?
Latest data suggests 23,000 work at Alcon.
When does the fiscal year end for Alcon?
Alcon's fiscal year ends in December.
Where is Alcon based?
Alcon's address is: Chemin de Blandonnet 8, Geneva, Switzerland

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site